Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis-Reference-Cited by-同舟云学术

Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis

Published:2020-10 Issue: Volume:885 Page:173523
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Cong Hengri,Zhang Ming,Chang Haoxiao,Du Li,Zhang Xinghu,Yin Linlin

Funder

Beijing Nova Star Program in Science and Technology

Capital Medical Development Special Program

Publisher

Elsevier BV

Subject

Pharmacology

Reference31 articles.

1. Monocyte and macrophage plasticity in tissue repair and regeneration;Das;Am. J. Pathol.,2015

2. MAP kinases in the immune response;Dong;Annu. Rev. Immunol.,2002

3. Role of microglia in neurological disorders and their potentials as a therapeutic target;Du;Mol. Neurobiol.,2017

4. Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis;Hendrickx;J. Neuropathol. Exp. Neurol.,2013

5. Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis;Jiang;Immunol. Lett.,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis;Frontiers in Immunology;2024-08-19

2. AR/RKIP pathway mediates the inhibitory effects of icariin on renal fibrosis and endothelial-to-mesenchymal transition in type 2 diabetic nephropathy;Journal of Ethnopharmacology;2024-02

3. Icariin ameliorates the cuprizone-induced demyelination associated with antioxidation and anti-inflammation;Inflammopharmacology;2024-01-04

4. Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis;Brain Research;2024-01

5. Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis;Journal of Controlled Release;2023-12